NEUROCRINE BIOSCIENCES INC (NBIX)

US64125C1099 - Common Stock

136.03  +0.45 (+0.33%)

After market: 139.398 +3.37 (+2.48%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.89B1.49B1.13B1.05B788.10M
Cost Of Goods
39.70M23.20M14.30M10.10M7.40M
Gross Profit
1.85B1.47B1.12B1.04B780.70M
Operating Expenses
1.45B1.21B911.40M708.30M554.10M
Research and Development
565.00M463.80M328.10M275.00M200.00M
Selling, General, and Administrative Expenses
887.60M751.00M583.30M433.30M354.10M
Operating Income
394.80M250.70M207.80M327.50M226.60M
Interest Income/Expense
81.20M34.90M-1.10M-37.90M-25.70M
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
-143.90M-71.70M-105.30M-182.90M-154.30M
Income Before Taxes
332.10M213.90M101.40M106.70M46.50M
Income Tax
82.40M59.40M11.80M-300.60M9.50M
Net Income
249.70M154.50M89.60M407.30M37.00M
EBITDA
416.10M266.30M218.70M336.10M234.10M
 
Per Share Data
EPS Diluted Total Ops
2.471.560.924.160.39
Non GAAP EPS
2.421.531.321.300.33
 
Statistics
Gross Profit Margin
97.90%98.44%98.74%99.03%99.06%
Profit Margin
13.23%10.38%7.90%38.94%4.69%
Operating Profit Margin
20.92%16.84%18.33%31.31%28.75%

All data in USD

Charts